Company / Revenue per Share
Cytokinetics Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$733.03
FY2025
5-year range
$0.08 / $733.03
FY2021-FY2025
Trend
+403188.7%
vs FY2024
Sector context
#1 of 154
Health Care
What the data says
Revenue per Share changed +403189% YoY in FY2025, a notable deviation from the 9-year average annual change of +44818%.
Based on SEC 10-K filings.
733.03 in FY2025 with a 5-year CAGR of +292.6%. Ranks 1st among 154 companies in Health Care.
Improved from $0.08 to $733.03 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +769.4%
- 5-Year CAGR
- +292.6%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 154This company $733.03 Sector average $15.09
▼
+4757.6% above sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 403188.7% year-over-year.
- Ranks #1 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $733.03 | +403188.7% |
| FY2024 | $0.18 | +128.9% |
| FY2023 | $0.08 | -92.9% |
| FY2022 | $1.12 | +34.3% |
| FY2021 | $0.83 | +5.6% |
| FY2020 | $0.79 | +73.1% |
| FY2019 | $0.45 | -21.1% |
| FY2018 | $0.58 | +132.4% |
| FY2017 | $0.25 | -90.5% |
| FY2016 | $2.62 | +261.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026